Pacific Northwest Research Institute
Seattle, Washington, 98122, United States
NCT Number: NCT00609102
This study examines whether an antioxidant taken orally will improve glucose tolerance and insulin secretion in type 2 diabetic subjects.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Early Phase 1
Seattle, Washington, 98122, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Subjects with a known diagnosis of type 2 diabetes -
Exclusion criteria
None, except known intolerance to n-acetylcysteine
-
one capsule BID
450 mgm BID
Time frame: 3 months
Time frame: 3 months
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06283992
Diabetes Mellitus, Diabetes Mellitus, Type 2
Boston, Massachusetts, United States
View Trial DetailsNCT05623189
Diabetes Mellitus, Diabetes Mellitus, Type 2
Chandler, Arizona, United States
View Trial DetailsNCT04536480
Behavior, Body Weight
Los Angeles, California, United States
View Trial DetailsNCT06900946
Diabetes Mellitus, Diabetes Mellitus, Type 2
Tehran, Iran
View Trial Details